Forbes December 19, 2025
In this week’s edition of The Prototype, we look at a drug to help spinal injuries, a crypto billionaire’s big space play, revitalizing aging immune systems and more.
Every year, around 18,000 Americans will suffer a traumatic spinal cord injury. This can lead to a number of complications, including paralysis or limited movement in the limbs, spasticity and other health impacts. And right now, there are no treatments apart from physical therapy, which only has limited utility.
But a recent clinical trial suggests there may be a new treatment on the horizon for some patients, which right now is called NVG-291. Developed by Vancouver, Canada-based NervGen, the drug is injected into the body and then gets to work. In many...
Today's Sponsors
Today's Sponsor